Magnésium + B6
Food supplement declared in France, declaration No 2019-7-134
Magnésium + B6 is a food supplement declared in France. Status: retrait du marché annoncé pour le 3 November 2028. 1 point in its composition requires a check (prohibited substance, dose or novel food).
- Brand
- not provided
- Food business operator placing the product on the market
- New Stefal Holding
- Status
- Retrait du marché annoncé pour le 3 November 2028
- Form
- Gélule
- Daily dose
- 4 gélules
- Directions for use
- Prendre 2 gélules au milieu de chacun des 2 principaux repas avec un grand verre d'eau.
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Femmes enceintes
- Objectives stated by the manufacturer (these are not authorised claims)
- Système nerveux
Declaration 213769, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- À vérifier
The composition lists additive E171 (titanium dioxide), removed from the list of additives allowed in food, supplements included: since 7 August 2022, a supplement containing it can no longer be placed on the market in the Union.
Source: Regulation (EU) 2022/63: titanium dioxide (E171) removed from the food additives allowed in the EU, règlement (UE) 2022/63.
- Information
Retrait du marché annoncé pour le 3 November 2028, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Carbonate de magnésium | Magnésium | 250 mg | 300 mg |
| Chlorhydrate de pyridoxine | Vitamine B6 | 12 mg | 2 mg |
Additives
E470b, E551, E171
Other ingredients
gélatine
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Ne convient pas aux femmes enceintes ou qui allaitent. Tenir hors de portée des jeunes enfants.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.